Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
Not Confirmed
Not Confirmed
07-09 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
03 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/03/2991045/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
25 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/25/2986570/0/en/Intellia-Therapeutics-Announces-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-Granted-to-Nexiguran-Ziclumeran-nex-z-for-the-Treatment-of-Hereditary-Transthyretin-ATTR.html
18 Nov 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/intellias-crispr-and-alnylams-rnai-data-drops-present-contrasting-visions-cardiomyopathy
16 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/16/2982349/0/en/Intellia-Announces-First-Clinical-Evidence-from-Ongoing-Phase-1-Study-that-Nexiguran-Ziclumeran-nex-z-an-In-Vivo-CRISPR-Cas9-Based-Gene-Editing-Therapy-May-Favorably-Impact-Disease.html
07 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/07/2976563/0/en/Intellia-Therapeutics-Announces-Third-Quarter-2024-Financial-Results-and-Highlights-Recent-Company-Progress.html
05 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/05/2975191/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?